These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 9263629)
1. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629 [TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers. Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673 [TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-2 and bcl-X in bladder cancer. Kirsh EJ; Baunoch DA; Stadler WM J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882 [TBL] [Abstract][Full Text] [Related]
5. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Huang J; Tan PH; Thiyagarajan J; Bay BH Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061 [TBL] [Abstract][Full Text] [Related]
8. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer. Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145 [TBL] [Abstract][Full Text] [Related]
10. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122 [TBL] [Abstract][Full Text] [Related]
11. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma. Lee WY; Jin YT; Tzeng CC Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421 [TBL] [Abstract][Full Text] [Related]
13. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413 [TBL] [Abstract][Full Text] [Related]
14. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
16. bcl-2 and apoptosis in lymph node positive breast carcinoma. Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021 [TBL] [Abstract][Full Text] [Related]
17. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
18. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147 [TBL] [Abstract][Full Text] [Related]
19. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level. Martínez-Arribas F; Alvarez T; Del Val G; Martín-Garabato E; Núñez-Villar MJ; Lucas R; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2007; 27(1A):219-22. PubMed ID: 17352236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]